Enkephalins are the physiological ligands of opioid receptors, and apart from their role in pain perception, they may benefit mood and reduce stress when upregulated [11]
Ferrannini 1,7
The 15 new drugs are the second group of medications set to undergo the process
Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, which reflect hepatocellular injury, typically decrease during GLP-1 therapy
Duan N, Zhang YH, Wang WM, Wang X
described the non-suppressible insulin-like activity (NSILA) of two soluble serum components (NSILA I and II) by the fact that they stimulated glucose uptake into isolated rat adipocytes, sharing insulin-like activity, while anti-insulin antibodies were not able to abrogate their hypoglycemic effects[3]